OncoSec Medical Inc (ONCSQ)

[chickpea598]

looking at Avacta's website and their pipeline I think you are exactly right. Avacta quote: The company has initiated its first internal programme targeting PD-L1 inhibition in order to rapidly progress the first Affimer therapeutic to the clinic

From the pr today put out by Avacta:
"The collaboration between the companies aims to show that, by using ImmunoPulse to deliver DNA encoding Avacta's immuno-modulatory Affimers, including Avacta's PD-L1 inhibitor (AVA04), into tumor cells and other tissues, a clinically relevant dose can be achieved. The companies plan to then demonstrate efficacy of the Affimers in a relevant in vivo tumor model."